CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit | −2,727 | 8,178 | ||
| 2023-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Restricted Share Unit | +7,091 | 7,091 | ||
| 2023-09-01 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award · Share Option | +42,544 | 42,544 | ||
| 2023-09-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +2,498 | 44,408 | ||
| 2023-09-01 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes 10b5-1 | −734 | $17.76 | $13K | 43,674 |
| 2023-09-01 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −2,498 | 7,492 | ||
| 2023-09-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Restricted Share Unit 10b5-1 | +6,496 | 6,496 | ||
| 2023-09-01 | Paolini John F. CHIEF MEDICAL OFFICER | Grant or award · Share Option 10b5-1 | +38,974 | 38,974 | ||
| 2023-07-25 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +29,000 | $1.86 | $54K | 70,910 |
| 2023-07-25 | Paolini John F. CHIEF MEDICAL OFFICER | Sale | −5,200 | $18.01 | $94K | 65,710 |
| 2023-07-25 | Paolini John F. CHIEF MEDICAL OFFICER | Sale | −16,168 | $19.25 | $311K | 49,542 |
| 2023-07-25 | Paolini John F. CHIEF MEDICAL OFFICER | Sale | −7,632 | $19.69 | $150K | 41,910 |
| 2023-07-25 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option | −29,000 | 140,217 | ||
| 2023-07-15 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award | +581 | $12.35 | $7K | 13,558 |
| 2023-07-15 | Moat Ross CHIEF COMMERCIAL OFFICER | Grant or award | +292 | $12.35 | $4K | 12,845 |
| 2023-06-29 | Malley Thomas Director | Option exercise | +5,000 | 5,000 | ||
| 2023-06-29 | Malley Thomas Director | Option exercise · Restricted Share Units | −5,000 | 0 | ||
| 2023-06-29 | McCain Tracey L Director | Option exercise | +5,000 | 5,000 | ||
| 2023-06-29 | McCain Tracey L Director | Option exercise · Restricted Share Units | −5,000 | 0 | ||
| 2023-06-29 | Levy Richard S Director | Option exercise | +5,000 | 5,000 |
Page 59 of 74 · 1,467 trades